Hospital
Saint Francis Hospital South LLC
Saint Francis Hospital South LLC was paid $11.12M by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 99284, emergency room visit (serious) — 43% of everything it billed.
33Billing provider infoSAINT FRANCIS HOSPITAL SOUTH LLC
TULSA, OK 74133
TULSA, OK 74133
33aNPI1376561944assigned 07/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.12M
24GClaims121,347
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#13 of 75
Median peer was paid$3.66M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,205 | $653K | |
| 2019 | 8,818 | $893K | |
| 2020 | 8,452 | $828K | |
| 2021 | 17,726 | $1.59M | |
| 2022 | 32,042 | $2.67M | |
| 2023 | 34,789 | $3.16M | |
| 2024incomplete | 12,315 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 43% | 18,971 | 18,839 | $4.81M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 15,659 | 15,596 | $2.64M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 3,630 | 3,615 | $1.36M |
| 87631 | 5.4% | 4,783 | 4,774 | $599K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.3% | 4,547 | 4,504 | $593K |
| 80053 | Comprehensive metabolic panel | 2.2% | 16,875 | 16,721 | $243K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 3,802 | 3,618 | $181K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,961 | 2,853 | $140K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 18,282 | 18,089 | $121K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 489 | 489 | $81K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,316 | 5,292 | $69K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,536 | 1,527 | $43K |
45 more codes
| 84703 | <1% | 5,705 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 629 | $32K |
| 81001 | <1% | 7,481 | $26K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 51 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,648 | $15K |
| 83690 | <1% | 2,570 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 204 | $14K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 134 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 54 | $9K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 176 | $9K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 14 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,830 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 38 | $5K |
| 84484 | <1% | 484 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 88 | $4K |
| 87807 | <1% | 227 | $3K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 31 | $3K |
| 74230 | <1% | 31 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 155 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 41 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 155 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 25 | $2K |
| 87070 | <1% | 149 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $945.00 |
| 94060 | <1% | 28 | $533.37 | |
| 94761 | <1% | 527 | $481.98 | |
| 71250 | <1% | 14 | $473.64 | |
| 83605 | <1% | 28 | $277.83 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $253.53 |
| 74018 | <1% | 13 | $251.44 | |
| 87430 | <1% | 17 | $242.08 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $219.76 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 556 | $204.32 |
| 36415 | Collection of venous blood by venipuncture | <1% | 42 | $158.78 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24 | $150.78 |
| 83735 | <1% | 25 | $143.04 | |
| 82550 | <1% | 13 | $81.06 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $15.84 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 111 | $0.00 |
| 99152 | 0% | 12 | $0.00 | |
| 92611 | 0% | 31 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 12 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 15 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 31 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, BARRY (SYSTEM DIRECTOR, REV CYCLE SUPPORT)
| Provider | Location | Paid |
|---|---|---|
| Saint Francis Hospital Muskogee INC | Muskogee, OK | $16.79M |
| Saint Francis Outreach Services LLC | Tulsa, OK | $15.74M |
| Saint Francis Hospital Vinita, INC | Vinita, OK | $6.44M |
| Laureate Psychiatric Clinic and Hospital INC | Tulsa, OK | $729K |
| Saint Francis Hospital South LLC | Tulsa, OK | $51K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.